We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
17:00 - 18:00
A6
Functional biomarkers and prediction models 2
Emmy Dalqvist, Sweden;
Livia Marrazzo, Italy
Mini-Orals
Physics
17:00 - 18:00
Introduction of the world's largest temporal FDG-PET/CT oligometastatic disease dataset and required tools
Maksym Fritsak, Switzerland
-2791
17:00 - 18:00
Spatial correlation of FDG PET and FAZA PET for head and neck cancer and its impact on more accessible hypoxia-driven dose escalation
Laura Rechner, Denmark
-4069
17:00 - 18:00
Multi-institutional in-vivo characterization of consensus measurement methods for T1 and T2 mapping on the 1.5T Unity MR-linac
Marielle Philippens, The Netherlands
-3869
17:00 - 18:00
Independent external validation of an ADC-based prognostic biomarker for outcomes after radiotherapy in head-and-neck cancer
Enrico Longhi, Italy
-3891
17:00 - 18:00
NTCP models for severe radiation-induced lymphopenia in lung cancer radiotherapy: a blood dose-based analysis of IMRT and IMPT
Shuting Wang, China
-2737
17:00 - 18:00
Normal tissue genetically-adjusted radiation dose (NT_GARD) for causal inference models of late toxicity after breast cancer radiotherapy
Benedetta Dionisi Ferrera, Italy
-4057
17:00 - 18:00
Radiomics and Dosiomics-Based Machine Learning Models for Predicting Radiation Esophagitis: Evidence from the Prospective RTOG 0617 and REQUITE Trials
Lukas Manuel Reuter, Germany
-1738
17:00 - 18:00
Validation of an NTCP model of moderate-severe late side effects after whole breast radiotherapy, including the impact of advanced delivery techniques
Monica Maria Vincenzi, Italy
-2731